Loading...
Header Logo
Keywords
Last Name
Institution

Dr Ramesh Panchagnula

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Panchagnula R, Bhardwaj V. Effect of amorphous content on dissolution characteristics of rifampicin. Drug Dev Ind Pharm. 2008 Jun; 34(6):642-9. PMID: 18568915.
      View in: PubMed
    2. Panchagnula R, Bindra P, Kumar N, Dey CS, Pillai O. Stability of insulin under iontophoretic conditions. Pharmazie. 2006 Dec; 61(12):1014-8. PMID: 17283659.
      View in: PubMed
    3. Panchagnula R, Kumar Bajpai A, Agrawal S, Ashokraj Y. Dissolution testing of marketed rifampicin containing fixed dose combination formulations using a new discriminative media: a post marketing retrospective study. Pharmazie. 2006 Oct; 61(10):851-4. PMID: 17069424.
      View in: PubMed
    4. Panchagnula R, Dhanikula RS, Dhanikula AB. An ex vivo characterization of Paclitaxel loaded chitosan films after implantation in mice. Curr Drug Deliv. 2006 Jul; 3(3):287-97. PMID: 16848730.
      View in: PubMed
    5. Panchagnula R, Parmar J, Kaur JK, Singh I, Bhade SR. Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations. Methods Find Exp Clin Pharmacol. 2006 Apr; 28(3):161-7. PMID: 16810342.
      View in: PubMed
    6. Panchagnula R, Parmar J, Kaur K, Singh I, Bade SR, Ashokraj Y. Statistical evaluation of physiological variability of rifampicin in fixed dose combinations. Int J Pharm. 2006 Apr 26; 313(1-2):5-13. PMID: 16517107.
      View in: PubMed
    7. Panchagnula R, Desu H, Jain A, Khandavilli S. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation. Farmaco. 2005 Nov-Dec; 60(11-12):894-9. PMID: 16126203.
      View in: PubMed
    8. Panchagnula R, Bokalial R, Sharma P, Khandavilli S. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int J Pharm. 2005 Apr 11; 293(1-2):213-23. PMID: 15778059.
      View in: PubMed
    9. Panchagnula R, Dravid P, Jain A, Khandavilli S. Single and multiple dose pharmacokinetic evaluation of a transdermal delivery system of imipramine hydrochloride. Arzneimittelforschung. 2005; 55(4):198-204. PMID: 15901042.
      View in: PubMed
    10. Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Sateesh K, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg B, Fourie B, Roscigno G, Wire R, Laing R, Evans P, Moore T. Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective. Methods Find Exp Clin Pharmacol. 2004 Nov; 26(9):703-21. PMID: 15632956.
      View in: PubMed
    11. Panchagnula R, Sharma P, Khandavilli S, Varma MV. RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation. Farmaco. 2004 Oct; 59(10):839-42. PMID: 15474062.
      View in: PubMed
    12. Panchagnula R, Desu H, Jain A, Khandavilli S. Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel. J Pharm Sci. 2004 Sep; 93(9):2177-83. PMID: 15295779.
      View in: PubMed
    13. Panchagnula R, Bansal T, Varma MV, Kaul CL. Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 05; 806(2):277-82. PMID: 15171939.
      View in: PubMed
    14. Panchagnula R, Sundaramurthy P, Pillai O, Agrawal S, Raj YA. Solid-state characterization of mefenamic acid. J Pharm Sci. 2004 Apr; 93(4):1019-29. PMID: 14999737.
      View in: PubMed
    15. Panchagnula R, Agrawal S. Biopharmaceutic and pharmacokinetic aspects of variable bioavailability of rifampicin. Int J Pharm. 2004 Mar 01; 271(1-2):1-4. PMID: 15129967.
      View in: PubMed
    16. Panchagnula R, Sharma A, Agrawal S. Plasma pooling methodology as a faster and cheaper tool to evaluate bioequivalence of rifampicin component of FDCs of antitubercular drugs. Pharmacol Res. 2003 Dec; 48(6):655-63. PMID: 14527833.
      View in: PubMed
    17. Panchagnula R, Sancheti P, Rungta S, Agrawal S, Kaul CL. Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol. Pharmacol Res. 2003 Oct; 48(4):383-7. PMID: 12902209.
      View in: PubMed
    18. Nair V, Panchagnula R. Poloxamer gel as vehicle for transdermal iontophoretic delivery of arginine vasopressin: evaluation of in vivo performance in rats. Pharmacol Res. 2003 Jun; 47(6):555-62. PMID: 12742011.
      View in: PubMed
    19. Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm. 2001 May 21; 219(1-2):95-105. PMID: 11337170.
      View in: PubMed
    20. Panchagnula R, Agrawal S, Kaur KJ, Singh I, Kaul CL. Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol. Int J Tuberc Lung Dis. 2000 Dec; 4(12):1169-72. PMID: 11144460.
      View in: PubMed
    21. Panchagnula R, Kaur KJ, Singh I, Kaul CL. Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations. Methods Find Exp Clin Pharmacol. 2000 Nov; 22(9):689-94. PMID: 11294011.
      View in: PubMed
    22. Panchagnula R, Pillai O, Nair VB, Ramarao P. Transdermal iontophoresis revisited. Curr Opin Chem Biol. 2000 Aug; 4(4):468-73. PMID: 10959777.
      View in: PubMed
    23. Panchagnula R, Jain AK, Pillai O, Jaiswal J. Nicotine transdermal systems: pharmaceutical and clinical aspects. Methods Find Exp Clin Pharmacol. 2000 Jun; 22(5):299-308. PMID: 11031731.
      View in: PubMed
    24. Panchagnula R, Kaur KJ, Singh I, Kaul CL. The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO. Int J Tuberc Lung Dis. 1999 Nov; 3(11 Suppl 3):S336-42; discussion S351-2. PMID: 10593714.
      View in: PubMed
    Panchagnula's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description